Viking Therapeutics (VKTX) Cash from Investing Activities (2015 - 2026)
Viking Therapeutics' (VKTX) quarterly Cash from Investing Activities came in at $109.4 million in Q2 2026, up 157.45% year-over-year from $42.5 million in Q2 2025, and up 101.94% quarter-over-quarter from $54.2 million in Q1 2026.
Powered by 
Analysis
Viking Therapeutics (VKTX) Cash from Investing Activities (2015 - 2026) Analysis & Trends
Viking Therapeutics has disclosed Cash from Investing Activities across 12 years of filings, most recently posting $109.4 million for Q2 2026.
- In Q2 2026, Cash from Investing Activities rose 157.45% year-over-year to $109.4 million; the TTM figure through Jun 2026 stood at $399.3 million (up 188.82% YoY), while the FY2025 annual figure was $341.4 million, up 161.69% from the prior year.
- Cash from Investing Activities came in at $109.4 million for Q2 2026 at Viking Therapeutics, up from $54.2 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $160.0 million in Q3 2025 to a low of -$459.8 million in Q1 2024.
- Average Cash from Investing Activities over 5 years is -$9.6 million, with a median of $22.4 million recorded in 2022.
- Year-over-year, Cash from Investing Activities plunged 21018.65% in 2024 and soared 1048.42% in 2025.
- Over 5 years, Cash from Investing Activities stood at $7.3 million in 2022, then jumped by 392.19% to $35.7 million in 2023, then slumped by 81.57% to $6.6 million in 2024, then soared by 1048.42% to $75.6 million in 2025, then jumped by 44.73% to $109.4 million in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were $109.4 million in Q2 2026, $54.2 million in Q1 2026, and $75.6 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | -1.11 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | -1.20 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | -5.60 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | -3.11 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | -2.91 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | -569.00 Mn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | -10.35 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 2.11 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | -45.80 Mn |
| 10 | Viking Therapeutics | 4.86 Bn | 4.86 Bn | - | 109.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 109.43 Mn |
| Mar 31, 2026 | 54.19 Mn |
| Dec 31, 2025 | 75.61 Mn |
| Sep 30, 2025 | 160.03 Mn |
| Jun 30, 2025 | 42.51 Mn |
| Mar 31, 2025 | 63.25 Mn |
| Dec 31, 2024 | 6.58 Mn |
| Sep 30, 2024 | 25.90 Mn |
| Jun 30, 2024 | -126.06 Mn |
| Mar 31, 2024 | -459.79 Mn |
| Dec 31, 2023 | 35.73 Mn |
| Sep 30, 2023 | -12.53 Mn |
| Jun 30, 2023 | -204.48 Mn |
| Mar 31, 2023 | 2.20 Mn |
| Dec 31, 2022 | 7.26 Mn |
| Sep 30, 2022 | 26.89 Mn |
| Jun 30, 2022 | 18.98 Mn |
| Mar 31, 2022 | 1.62 Mn |
| Dec 31, 2021 | 27.41 Mn |
| Sep 30, 2021 | 13.62 Mn |
API Access
Viking Therapeutics Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=VKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();